Randomized, Double-Blind, Placebo-Controlled, Global Phase III Trial of Talimogene Laherparepvec Combined With Pembrolizumab for Advanced Melanoma
Amgen
Jason A Chesney; Antoni Ribas; Georgina V Long; John M Kirkwood; Reinhard Dummer; Igor Puzanov; Christoph Hoeller; Thomas F Gajewski; Ralf Gutzmer; Piotr Rutkowski; Lev Demidov; Petr Arenberger; Sang Joon Shin; Pier Francesco Ferrucci; Andrew Haydon; John Hyngstrom; Johannes V van Thienen; Sebastian Haferkamp; Josep Malvehy Guilera; Bernardo Leon Rapoport; Ari VanderWalde; Scott J Diede; James R Anderson; Sheryl Treichel; Edward L Chan; Sumita Bhatta; Jennifer Gansert; Frank Stephen Hodi; Helen Gogas